We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2011 by Taipei Medical University WanFang Hospital.
Recruitment status was:  Active, not recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01322685
First Posted: March 24, 2011
Last Update Posted: March 24, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Taipei Medical University WanFang Hospital
March 23, 2011
March 24, 2011
March 24, 2011
July 2010
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens
Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens
The purpose of this study is to study the Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens. Subjects are divided into two groups which are health group and Tuberculosis or lung cancer group in order to compare with the difference.
Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Health people Tuberculosis or lung cancer
  • Tuberculosis
  • Lung Cancer
Not Provided
  • Health Group
  • Tuberculosis Group
    Tuberculosis or lung cancer group
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
40
June 2011
Not Provided

Inclusion Criteria:

  • Health group: between 17 to 90 years old
  • Tuberculosis group: people who are tuberculosis or lung cancer patients and between 17 to 90 years old

Exclusion Criteria:

  • Women subjects are before or after the period within two days
Sexes Eligible for Study: All
17 Years to 90 Years   (Child, Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
Taiwan
 
 
NCT01322685
99042
No
Not Provided
Not Provided
Kuo-Sheng Hung, Department of Neurosurgery, WanFang Hospital
Taipei Medical University WanFang Hospital
Not Provided
Principal Investigator: Kuo-Sheng Hung Taipei Medical University WanFang Hospital
Taipei Medical University WanFang Hospital
March 2011